Skip to main content
. 2020 May 5;11(6):1566–1577. doi: 10.1111/1759-7714.13430

Figure 4.

Figure 4

CM082 combined with gefitinib inhibited HCC827 and H3255 cell growth. (a) Dose‐dependent response curves of the effects of CM082 or gefitinib on the growth of HCC827 and H3255 cells. The histogram represents the mean ± standard deviation of three experiments. (b) Dose‐dependent response curves and combination index of CM082 plus gefitinib on the growth of HCC827 and H3255 cells.